198 related articles for article (PubMed ID: 18578335)
1. [Cytomegalovirus infection in renal transplant recipients].
Basić-Jukić N; Racki S; Kes P; Mustapić Z
Acta Med Croatica; 2008; 62 Suppl 1():69-75. PubMed ID: 18578335
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
[TBL] [Abstract][Full Text] [Related]
3. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
Ishibashi K; Tokumoto T; Tanabe K; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Inoue N; Yamaguchi O; Toma H; Suzutani T
Clin Infect Dis; 2007 Jul; 45(1):60-7. PubMed ID: 17554702
[TBL] [Abstract][Full Text] [Related]
4. Renal transplant and cytomegalovirus infection: experience in a community hospital program.
Matulis WS; Cokeley G; Matulis M; Funk E
W V Med J; 1992 Oct; 88(10):454-6. PubMed ID: 1333681
[TBL] [Abstract][Full Text] [Related]
5. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestation, laboratory findings, and the response of treatment in kidney transplant recipients with CMV infection.
Razeghi E; Hadadi A; Mansor-Kiaei M; Molavi M; Khashayar P; Pourmand G
Transplant Proc; 2007 May; 39(4):993-6. PubMed ID: 17524872
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.
Vancíková Z; Dvorák P
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):179-87. PubMed ID: 12476798
[TBL] [Abstract][Full Text] [Related]
8. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
9. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
Steininger C
Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749
[TBL] [Abstract][Full Text] [Related]
11. An unusual etiology of viral hepatitis in three renal transplant recipients with normal graft function.
Ionescu C; Ismail G; Constantinescu I; Hortopan M; Iliescu O; Rosu M; Voiculescu M
Rom J Gastroenterol; 2003 Dec; 12(4):303-7. PubMed ID: 14726976
[TBL] [Abstract][Full Text] [Related]
12. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
[TBL] [Abstract][Full Text] [Related]
13. Renal transplantation and related infections.
Hibberd PL; Rubin RH
Semin Respir Infect; 1993 Sep; 8(3):216-24. PubMed ID: 8016482
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'.
Rubin RH
Curr Opin Infect Dis; 2007 Aug; 20(4):399-407. PubMed ID: 17609600
[TBL] [Abstract][Full Text] [Related]
15. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation.
Legendre C; Beard SM; Crochard A; Lebranchu Y; Pouteil-Noble C; Richter A; Durand-Zaleski I
Eur J Health Econ; 2005 Jun; 6(2):172-82. PubMed ID: 15765243
[TBL] [Abstract][Full Text] [Related]
17. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
18. Beta-herpesvirus challenges in the transplant recipient.
Ljungman P
J Infect Dis; 2002 Oct; 186 Suppl 1():S99-S109. PubMed ID: 12353194
[TBL] [Abstract][Full Text] [Related]
19. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.
Choi YL; Kim JA; Jang KT; Kim DS; Kim WS; Lee JH; Yang JM; Lee ES; Lee DY
Br J Dermatol; 2006 Nov; 155(5):977-82. PubMed ID: 17034528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
